Gaucher disease: when molecular testing and clinical presentation disagree -the novel c.1226A>G(p.N370S)--RecNcil allele

By Balwani Manisha   Grace Marie   Desnick Robert  

Journal of Inherited Metabolic Disease, Vol. 34, Iss. 3, 2011-06 ,pp. : 789-793

Springer Publishing Company

Access to resources Recommend Favorite

TYPE I GAUCHER DISEASE IN CHILDREN WITH AND WITHOUT ENZYME THERAPY

By Dweck Altoon   Abrahamov Ayala   Hadas-Halpern Irith   Bdolach-Avram Tali   Zimran Ari   Elstein Deborah  

Pediatric Hematology and Oncology, Vol. 19, Iss. 6, 2002-09 ,pp. : 389-397

Informa Healthcare

Access to resources Recommend Favorite

Clinically relevant therapeutic endpoints in type I Gaucher disease

By Hollak C.   Maas M.   Aerts J.  

Journal of Inherited Metabolic Disease, Vol. 24, Iss. 2, 2001-04 ,pp. : 97-105

Springer Publishing Company

Access to resources Recommend Favorite

A neurological symptom survey of patients with type I Gaucher disease

By Pastores G. M.   Pastores G. M.   Barnett N. L.   Bathan P.   Kolodny E. H.  

Journal of Inherited Metabolic Disease, Vol. 26, Iss. 7, 2003-01 ,pp. : 641-645

Springer Publishing Company

Access to resources Recommend Favorite

IgM monoclonal component associated with type I Gaucher disease resolved after enzyme replacement therapy: A case report

By Martinez-Redondo C.   Ortuño F.   Lozano M.   Jerez A.   del Mar Osma M.   Giraldo P.   Vicente V.  

Journal of Inherited Metabolic Disease, Vol. 32, Iss. 1, 2009-12 ,pp. : 265-267

Springer Publishing Company

Access to resources Recommend Favorite